Scoliosis Specialists

Scoliosis is a an abnormal lateral curve to the vertebral column.  The degree of scoliosis can range from mild to severe. Scoliosis is most commonly an incidental and harmless finding. Patients with milder curves may only need to visit their doctor for periodic observation. Scoliosis may be congenital (a birth defect) or acquired (degenerative, arthritic, or traumatic).

Majority of the scoliosis cases are known as idiopathic. Since the true cause is unknown, the treatment can only be based on the symptoms. Until now, only two types of treatment have been known to be efficient: the first is the treatment using an orthopaedic rigid brace and the second one is surgery with a spinal system. Unfortunately only a few treatments have actually been shown to affect the outcome of scoliosis.

The treatment options of scoliosis depend on the severity and the age of the person.  Scoliosis bracing has been shown to be an effective method to prevent curves from getting worse. Until recently, this treatment was reserved for children and adolescents in whom the prediction of a rapid increase in the curve needs to be thwarted.  Today, there is spinecor, a revolutionary new soft flexible scoliosis brace that has changed the way we look at scoliosis treatment both in kids and adults.

SpineCor changes the dynamic of the trunk while harmonizing the posture. It is a therapeutic means with less mechanical constraints and an acceptable comfort level that preserves and enhances movements with a double therapeutic action:   Progressive correction of the spine deformation and Neuro-muscular stimulation and correction.

Results: For the total group of patients (Initial Cobb angle: 30 9) the trend during treatment wasa decrease in spinal curvature at three months with a mean difference of 9 (SD: 6), at termination of treatment (time ¼ 23 months) a mean difference of 5 (SD: 7); and at a follow-up time of 1, 2, 3 and 4 years there was a difference of 2  (SD: 7), 6  (SD: 5), 0  (SD: 8), and 8  (SD: 4) in reference to the initial condition. The survival analysis (G1 and G2) indicated a cumulative probability of success during follow-up without brace as follows. Year 1: probability (p) ¼ 1.00, 57

Abstracts (Confidence Interval (CI): 1.00 to 1.00) for G1,  p¼ 1.00 (CI: 1.00 to 1.00) for G2; Year 2: (p) ¼ 0.98 (CI: 0.93 to 1.00) for G1,  p¼ 0.92 (CI: 0.82 to 1.00) for G2; Year 3: p ¼0.92 (CI: 0.83 to 1.00) for G1, p¼ 0.92 (CI: 0.83 to 1.00) for G2; Year 4:  p¼ 0.88 (CI: 0.76 to 0.99) for G1, p ¼ 0.92 (CI: 0.73 to 1.00) for G2.